News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC
Saadvik Raghuram Y/LinkedIn
Jun 25, 2025, 20:47

Saadvik Raghuram Y: FDA Approves Talectrectinib for ROS1-Positive Locally Advanced or Metastatic NSCLC

Saadvik Raghuram Y, Head of Department of Medical Oncology at Arete Hospitals, shared a post on X:

“FDA approves Talectrectinib for ROS1-positive locally advanced or metastatic NSCLC.
  • Response rates in TKI naive (85-90%)
  • ORR in patients with prior TKI (52%)
  • CNS response rates in TKI Naive (73%), prior TKI (63%)
  • Watch out for Dizziness, QTc”

Read further.

Talectrectinib

More posts featuring Saadvik Raghuram Y on OncoDaily.

cancer FDA NSCLC OncoDaily Oncology ROS1-Positive NSCLC Saadvik Raghuram Y talectrectinib
Special Coverage
Voices
Aug 25, 2025, 19:00
Jarushka Naidoo: Irish Oncology in Full Force at the ESMO Academy 2025
Voices
Aug 25, 2025, 18:30
Shadha S. Al-Raisi: The Latest Cancer Incidence Report in Oman Has Been Released
Insight
Aug 25, 2025, 17:47
Alexey Kulikov: Key Findings from the Recent Meta-Analysis on Daily Steps and Health Outcomes
Voices
Aug 25, 2025, 17:36
Lauren Kriger Groner: Learning to Make White Ribbons from the Very Best
Science
Aug 25, 2025, 17:28
Galip Can Uyar: How GA-Guided Care Improves Coping in Older Adults with Metastatic Cancer
Science
Aug 25, 2025, 17:18
Giuseppe Banna: Deferred Nephrectomy after ICI in RCC May Enable Treatment De-Escalation
Science
Aug 25, 2025, 17:08
Moazzam Shahzad: Upfront Immunotherapy Approaches in the Management of Adults with ALL
Science
Aug 25, 2025, 17:00
Chris Poulios: Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
Voices
Aug 25, 2025, 16:44
Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era
Voices
Aug 25, 2025, 16:30
Sarcoma 101 at Fellowship Bootcamp with Steve Bialick - Miami Hematology Oncology Program Director
Science
Aug 25, 2025, 16:04
George Kumar Shares Breakthrough in Cold Plasma Oncology
Voices
Aug 25, 2025, 15:59
Cancer Research Institute Highlights Its Role in Immune-Based Cancer Breakthroughs